Diagnosing disease at the molecular level rapidly and with a high level of sensitivity and specificity is a critical capability for modern medicine. Rapid detection of small numbers of biomarkers of early disease in complex, heterogeneous clinical specimens represents a Holy Grail that will have a significant impact on human health.
|Original language||English (US)|
|Number of pages||5|
|Journal||Accounts of chemical research|
|State||Published - Mar 21 2017|
ASJC Scopus subject areas